Kappac Pharma (India) Buy Hold or Sell Recommendation

    KAPPH -- India Stock  

    INR 112.85  0.00  0.00%

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Kappac Pharma Ltd is 'Not Rated'. Macroaxis provides Kappac Pharma buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KAPPH positions. The advice algorithm takes into account all of Kappac Pharma available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from KAPPH buy-and-hold prospective. Please see also Stocks Correlation.

    Time Horizon

    Risk Tolerance

    Symbol
    Execute Advice
    Sell Kappac PharmaBuy Kappac Pharma
    Not Rated
    For the selected time horizon Kappac Pharma Ltd has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
    Macroaxis provides buy or sell recommendations on Kappac Pharma to complement and cross-verify current analyst consensus on Kappac Pharma. Our advice engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. Use Kappac Pharma Ltd Cash and Equivalents, Book Value Per Share as well as the relationship between Book Value Per Share and Total Asset to make sure your buy or sell decision on Kappac Pharma is adequate.

    Kappac Pharma Alerts

    Trading Alerts and Improvement Suggestions

    Kappac Pharma is not yet fully synchronised with the market data
    The company reported revenue of . Net Loss for the year was (786 K).
    Please see also Stocks Correlation. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
    Search macroaxis.com